Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial
Top Cited Papers
- 1 September 2001
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 358 (9286), 966-970
- https://doi.org/10.1016/s0140-6736(01)06103-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effect of Cytokine Therapy on Survival for Patients With Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 2000
- Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysisUrology, 2000
- Immunotherapy of Renal Cell CarcinomaUrologia Internationalis, 1999
- INTERLEUKIN-2 BASED IMMUNOTHERAPY FOR METASTATIC RENAL CELL CARCINOMA WITH THE KIDNEY IN PLACEJournal of Urology, 1999
- Laparoscopic cytoreductive nephrectomy as preparation for administration of systemic interleukin-2 in the treatment of metastatic renal cell carcinoma: a pilot studyUrology, 1999
- CYTOREDUCTIVE SURGERY BEFORE HIGH DOSE INTERLEUKIN-2 BASED THERAPY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMAJournal of Urology, 1997
- NEPHRECTOMY BEFORE INTERLEUKIN-2 THERAPY FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMAJournal of Urology, 1997
- A phase II study of interferon‐α, interleukin‐2 and 5‐fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activationBritish Journal of Urology, 1996
- Cytoreductive Surgery for Stage IV Renal Cell CarcinomaJournal of Urology, 1995
- Immunotherapy for renal cell carcinoma: The era of interleukin-2-based treatmentUrology, 1995